Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Total Current Liabilities (2016 - 2025)

Nutex Health's Total Current Liabilities history spans 16 years, with the latest figure at $157.9 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 12.1% year-over-year to $157.9 million; the TTM value through Dec 2025 reached $157.9 million, up 12.1%, while the annual FY2025 figure was $157.9 million, 12.1% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $157.9 million at Nutex Health, down from $194.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $194.9 million in Q2 2025 and bottomed at $6.9 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $57.4 million (2022), against an average of $72.2 million.
  • The largest annual shift saw Total Current Liabilities surged 3190.42% in 2021 before it increased 0.43% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $37.7 million in 2021, then skyrocketed by 45.56% to $54.9 million in 2022, then grew by 6.29% to $58.3 million in 2023, then surged by 141.57% to $140.9 million in 2024, then grew by 12.1% to $157.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Total Current Liabilities are $157.9 million (Q4 2025), $194.9 million (Q2 2025), and $176.6 million (Q1 2025).